je.st
news
Opexa Therapeutics Inc (OPXA) Upgraded to "Buy" by Zacks Investment Research
2016-01-25 01:16:11| Biotech - Topix.net
The firm presently has a $2.00 price target on the biopharmaceutical company's stock. Zacks Investment Research 's target price indicates a potential upside of 4.04% from the stock's current price.
Tags: buy
research
investment
upgraded
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||